Pilot Study on the Use of Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy for Diagnosing and Characterizing Cardiac Amyloidosis
Amyloidosis diagnosis relies on Congo red staining with immunohistochemistry and immunofluorescence for subtyping but lacks sensitivity and specificity. Laser-microdissection mass spectroscopy offers better accuracy but is complex and requires extensive sample preparation. Attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy offers a promising alternative for amyloidosis characterization. Cardiac tissue sections from nine patients with amyloidosis and 20 heart transplant recipients were analyzed using ATR-FTIR spectroscopy. Partial least squares discriminant analysis (PLS-DA), principal component analysis (PCA), and hierarchical cluster analysis (HCA) models were used to differentiate healthy post-transplant cardiac tissue from amyloidosis samples and identify amyloidosis subtypes [κ light chain (<i>n</i> = 1), λ light chain (<i>n</i> = 3), and transthyretin (<i>n</i> = 5)]. Leave-one-out cross-validation (LOOCV) was employed to assess the performance of the PLS-DA model. Significant spectral differences were found in the 1700-1500 cm<sup>-1</sup> and 1300-1200 cm<sup>-1</sup> regions, primarily related to proteins. The PLS-DA model explained 85.8% of the variance, showing clear clustering between groups. PCA in the 1712-1711 cm<sup>-1</sup>, 1666-1646 cm<sup>-1</sup>, and 1385-1383 cm<sup>-1</sup> regions also identified two clear clusters. The PCA and the HCA model in the 1646-1642 cm<sup>-1</sup> region distinguished κ light chain, λ light chain, and transthyretin cases. This pilot study suggests ATR-FTIR spectroscopy as a novel, non-destructive, rapid, and inexpensive tool for diagnosing and subtyping amyloidosis. This study was limited by a small dataset and variability in measurements across different instruments and laboratories. The PLS-DA model's performance may suffer from overfitting and class imbalance. Larger, more diverse datasets are needed for validation.
Authors
- Annelore Vandendriessche (ORCID: https://orcid.org/0009-0000-3904-1481)
- Marijn M. Speeckaert (ORCID: https://orcid.org/0000-0001-9183-4390)
- Charlotte Delrue (ORCID: https://orcid.org/0000-0002-2397-9931)
- Amélie Dendooven (ORCID: https://orcid.org/0000-0002-9900-7952)
- Sander De Bruyne (ORCID: https://orcid.org/0000-0002-9041-4404)
- Malaïka Van Der Linden (ORCID: https://orcid.org/0000-0003-0249-908X)
Institutions
- Ghent University Hospital (BE)
- Research Foundation - Flanders (BE)
- Ghent University (BE)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3390/ijms25179358
- Citations
- 3
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- Universiteit Gent